サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1138306

医療用特殊バッグの世界市場-2022-2029

Global Medical Specialty Bags Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医療用特殊バッグの世界市場-2022-2029
出版日: 2022年10月18日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

世界の医療用特殊バッグ市場の成長は、オストミー手術などの外科手術の増加など、特定の要因に牽引されています。大腸がん、憩室炎、IBDなどいくつかの疾患の発生率が増加していることが、外科的処置の需要を促進していることが、市場成長を促進する重要な要因の一つとなっています。

外科手術の増加は、予測期間中、世界の医療用特殊バッグ市場を牽引すると予想されます。

外科手術は多くの出血を伴い、輸血の必要性があるため、血液や血液成分の移送、腎透析、収集・加工・保管などに使用される医療用特殊バッグの採用率が高くなっています。したがって、外科手術、透析、輸血処置の増加により、予測期間中の市場成長が促されると予想されます。

高齢者人口の増加は、尿失禁の発生率増加の主な要因の1つであり、採尿バッグの需要を促進すると予想されます。高齢者層は尿失禁を起こしやすいため、医療用特殊バッグの需要が高まっています。疾病対策予防センター（CDC）によると、慢性腎臓病（CKD）は45～64歳（13%）や18～44歳（7%）よりも65歳以上（38%）に多くみられます。いくつかの国では、国民の年齢層が現在進行形で変化していることに起因する問題に直面しています。国連の経済社会局人口部によると、2017年、60歳の世界人口は今後30年の間に2倍に、80歳の人口は3倍になると言われています。

さらに、ヘルスケア分野における技術の進歩や医療施設の充実が進んでいることから、医療用特殊バッグ市場は予測期間中に大きく成長すると予想されます。衛生と健康に対する意識の高まりが、医療用特殊バッグ市場の成長を促進しています。また、政府組織からの支援の拡大は、ヘルスケアインフラへの投資、有利な償還政策、研究開発活動の奨励を促進するため、市場の成長にプラスの影響を与えます。

COVID-19の影響分析

COVID-19の発生により、研究所はコロナウイルスの症状を早期に抑えることができる解決策を見つけるために、研究開発を強化しています。COVID-19の予後を改善するために、免疫グロブリンとLMWH（低分子ヘパリン）抗凝固剤の静脈内投与が有望であることが確認されました。そのため、輸液バッグやその他の医療用特殊バッグ市場の企業はこの動向に注目し、COVID-19が流行する中、生産能力を高めるための努力を重ねています。免疫グロブリン静注療法とLMWH抗凝固療法は、末梢血中のリンパ球とBリンパ球を低下させ、患者の改善をもたらします。COVID-19患者における免疫グロブリンおよびLMWH抗凝固剤の静脈内投与開始は、医療用特殊バッグのメーカーに収益機会をもたらすと予測されます。しかし、原材料の入手不足や供給の遅れは、COVID-19のために包装メーカーが現在市場で直面している課題の一部です。

産業分析

医療用特殊バッグの世界市場は、ポーターのファイブフォース分析、サプライチェーン分析、規制分析、価格分析、疫学、パイプライン分析、アンメットニーズなどの様々な産業要因に基づいて、市場の詳細な分析を提供します。

世界の医療用特殊バッグ市場レポートでは、約40以上の市場データ表、45以上の図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

  • 製品別市場内訳
  • エンドユーザー別市場内訳
  • 地域別市場内訳

第4章 市場の力学

  • 市場影響要因
  • 促進要因
    • 外科手術、透析、輸血処置の増加
    • 尿失禁を起こしやすい老人の増加
  • 抑制要因
    • 保険償還の欠如
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • 疫学
  • パイプライン分析
  • サプライチェーン分析
  • 価格設定分析
  • 法規制分析
  • アンメットニーズ

第6章 製品別

  • 採尿バッグ
  • 連続携行式腹膜透析（CAPD）用バッグ
  • 麻酔用呼吸バッグ
  • 血液バッグ
  • オストミー用採尿バッグ
    • シングルユーズバッグ
    • 複数回使用可能なバッグ
  • 経腸栄養バッグ
  • 胆汁採取用バッグ
  • 無菌包装袋
  • 蘇生用バッグ
    • ディスポーザブルバッグ
    • 再利用可能なバッグ
  • 点滴用バッグ
    • PVC製バッグ
    • 非塩ビ素材系輸液バッグ
  • 死体袋
  • 浣腸バッグ
  • アイスバッグ

第7章 エンドユーザー別構成比

  • 病院
  • 外科センター
  • ヘルスケアセンター
  • 在宅ヘルスケア
  • その他

第8章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第9章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第10章 企業プロファイル

  • B. Braun Melsungen AG
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Baxter International Inc.
  • Coloplast AS
  • ConvaTec Group Plc
  • Hollister Inc.
  • Becton, Dickinson, and Co.
  • Cardinal Health Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Terumo Corporation
  • Kawasumi Laboratories Inc（List Not Exhaustive）

第11章 DataM

目次
Product Code: DMHOS2611

Market Overview

Medical specialty bags market size was valued at US$ 10.44 billion in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.9% during the forecast period (2022-2029).

Medical specialty bags are used in various applications such as urine collection, blood storage, bile collection, enteral feeding, sterile packaging, among others. These collection bags are manufactured with advanced materials to enhance their quality and are used to avoid any contamination. These medical specialty bags are highly used in hospitals to prevent the risk of any disease or infection. The rising demand for aseptic conditions in the medical institutes has increased the popularity of medical specialty bags globally.

Market Dynamics

The global medical specialty bags market growth driven by certain factors such as by increasing surgical procedures, such as ostomy procedures. The increasing incidence of several disorders such as colorectal cancer, diverticulitis, and IBD is driving the demand for surgical procedures are among the key factors driving the market growth.

Increasing surgical procedures, is expected to drive the global medical specialty bags market during the forecast period

The surgical procedures involve a lot of blood loss, and there is a need for blood transfusions, which is leading to higher adoption of medical specialty bags as these are used for the transfer of blood and blood components, renal dialysis and collection, processing, and storage. Therefore, the increasing number of surgical procedures, dialysis, and blood transfusion procedures are expected to stimulate market growth over the forecast period.

The growing geriatric population is one of the major factors responsible for the increase in incidences of urinary incontinence which is expected to drive the demand for urinary collection bags. Since the aged population is more prone to urinary incontinence, the demand for medical specialty bags is increasing. Chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (13%) or 18-44 years (7%) according to Centers for Disease Control and Prevention (CDC). Several countries are facing challenges due to the ongoing and increasing demographic shift in age among their people. According to the Department of Economic and Social Affairs Population Division of United Nations, 2017, the world's population who are 60 years old will double and those of 80 years old will triple during the next 30 years.

Furthermore, the medical specialty bags market is expected to grow significantly over the forecast period due to the increasing technological advancements in the healthcare sector and improved medical facilities. The increasing awareness of hygiene and health is fuelling the growth of the medical specialty bags market. Also, growing support from government organizations positively affects market growth since they facilitate investments in the healthcare infrastructure, favorable reimbursement policies, and encouraging research and development activities.

COVID-19 Impact Analysis

Due to the outbreak of COVID-19, research labs have increased their research & development to find solutions that can minimize the symptoms of coronavirus at early stages. It is observed that the intravenous immunoglobulin and LMWH (Low-molecular-weight heparin) anticoagulant therapy holds promising potentials in improving the COVID-19 prognosis. Hence, companies in the IV bags and other medical specialty bags market are focusing on this trend and increasing their efforts to boost the production capabilities amidst the COVID-19 pandemic. Intravenous immunoglobulin and LMWH anticoagulant therapy can lower the lymphocytes and B lymphocytes in peripheral blood, resulting in improvements in patients. The initiation of IV immunoglobulin and LMWH anticoagulant therapy in COVID-19 patients is projected to create revenue opportunities for manufacturers of medical specialty bags. However, lack of raw material availability and delayed supplies are some of the challenges that packaging manufacturers are currently facing in the market due to COVID-19.

Industry Analysis

The global medical specialty bags market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, epidemiology, pipeline analysis, unmet needs.

Segment Analysis

The ostomy collection bags segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Based on product, the global medical specialty bags market is segmented into urinary collection bags, continuous ambulatory peritoneal dialysis (CAPD) bags, anesthesia breathing bags, blood bags, ostomy collection bags, enteral feeding bags, bile collection bags, sterile packaging bags, resuscitation bags, intravenous fluid bags, cadaver bags, enema bags, and ice bags. Among these, the ostomy collection bags is estimated to dominated the global medical specialty bags market during the forecast period. These are available in either single-use bags or multiple-use bags. The SenSura Mio Baby ostomy bag manufactured by Coloplast is characterized by its long wear time, which ensures that premature babies are not disturbed. The bag adhesive is designed for sensitive skin and easy reuse. It stays on the baby's belly when the bag is changed. The SenSura Mio Kids ostomy bag is covered in a skin-friendly textile and discreet under clothing.

The Intravenous fluid bags are estimated to grow at the fastest growth rate over the forecast period, due to their various applications such as maintaining the correct electrolyte imbalance, sustaining and balancing the basal hydration level, and expanding IV volumes hypovolemic state in patients. Also, IV fluid bags are used in various healthcare processes along with the convenience and ease with to provide nutrition to any patient. However, the IV bags market is expected to experience a few challenges owing to the consequences of sterilizing IV bags. Also, with growing environmental impacts associated with the use of PVC, demand is anticipated to shift towards non-PVC material over the forecast period.

The IV bags market is predicted to reach an output of over 5,000 units by the end of 2027. However, a shortage of IV fluids in the U.S. healthcare system is likely to hamper the market for IV bags. Hence, pharmaceutical companies are adopting several strategies to strengthen their supply chains in the U.S. For instance, B. Braun has launched its Solutions for Life initiative by investing in IV therapy manufacturing facilities to ensure long-term supplies for the U.S. healthcare systems. Such initiatives are helpful for companies in the IV bags market.

Geographical Analysis

North America region holds the largest market share of the global medical specialty bags market

North America region is dominating the global Medical Specialty Bags market accounted for the largest market share in 2021, owing to rising incidences of chronic disorders and increasing surgical procedures which increases the demand for medical specialty bags. As per the National Association for Incontinence (NAFC), in North America, nearly 200 million people are affected by urinary incontinence. The United States and Canada are the key contributing regions for medical specialty bags in North America, owing to well-established healthcare infrastructure and favorable reimbursement policies in these countries.

Competitive Landscape

The medical specialty bags market is highly competitive and consists of several major players and the emergence of new players in the market. Some of the key players which are contributing to the growth of the market are B. Braun Melsungen AG, Baxter International Inc., Coloplast AS, ConvaTec Group Plc, Hollister Inc., Becton, Dickinson and Co., Cardinal Health Inc., Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Kawasumi Laboratories Inc, among others.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the medical specialty bags market globally. For instance, in May 2019, B. Braun Medical has announced that it is investing $1 billion into new and existing IV fluid manufacturing facilities to address the IV solution shortage exacerbated by Hurricane Maria's making landfall in Puerto Rico.

Key Companies to Watch

B. Braun Melsungen AG

Overview: B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, and pain therapy products, as well as infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, and ostomy, disinfection, and wound care products.

Product Portfolio: Flexima Uro Silk Flat Urostomy Bags- The Flexima Uro Silk convex urostomy bags are designed for people with flush or slightly retracted urostoma.

The global medical specialty bags market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market snippet by End-User
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Rising surgical, dialysis, and blood transfusion procedures
    • 4.2.2. Growing geriatric population prone to urinary incontinence
  • 4.3. Restraints:
    • 4.3.1. Lack of reimbursement
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology
  • 5.3. Pipeline Analysis
  • 5.4. Supply Chain Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Unmet Needs

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    • 6.1.2. Market Attractiveness Index, By Product Segment
  • 6.2. Urinary Collection Bags*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.3. Continuous ambulatory peritoneal dialysis (CAPD) bags
  • 6.4. Anesthesia breathing bags
  • 6.5. Blood bags
  • 6.6. Ostomy collection bags
    • 6.6.1. Single-use bags
    • 6.6.2. Multiple-use bags
  • 6.7. Enteral feeding bags
  • 6.8. Bile collection bags
  • 6.9. Sterile packaging bags
  • 6.10. Resuscitation bags
    • 6.10.1. Disposable bags
    • 6.10.2. Reusable bags
  • 6.11. Intravenous (IV) fluid bags
    • 6.11.1. PVC material based fluid bags
    • 6.11.2. Non- PVC material based fluid bags
  • 6.12. Cadaver bags
  • 6.13. Enema bags
  • 6.14. Ice bags

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 7.1.2. Market Attractiveness Index, By End-User Segment
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Surgical Centers
  • 7.4. Healthcare centers
  • 7.5. Home Healthcare
  • 7.6. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. The U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. The U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. The Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. B. Braun Melsungen AG*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Baxter International Inc.
  • 10.3. Coloplast AS
  • 10.4. ConvaTec Group Plc
  • 10.5. Hollister Inc.
  • 10.6. Becton, Dickinson, and Co.
  • 10.7. Cardinal Health Inc.
  • 10.8. Fresenius Medical Care AG & Co. KGaA
  • 10.9. Terumo Corporation
  • 10.10. Kawasumi Laboratories Inc (List Not Exhaustive)

11. DataM Intelligence

  • 11.1. Appendix
  • 11.2. About Us and Services
  • 11.3. Contact Us